September 30, 2016 4:52 PM ET


Company Overview of Aton Pharma, Inc.

Company Overview

Aton Pharma, Inc. develops pharmaceutical products focusing on ophthalmology and certain orphan drug indications. It offers medically essential treatments for serious and life-threatening medical conditions. The company focuses on the ophthalmic and orphan drug markets. Its marketed products include Mephyton, Edecrin, Sodium Edecrin, Cuprimine, Syprine, Demser, and Lodosyn for orphan diseases; and Lacrisert, Timoptic, Timoptic-XE, and Timoptic in Ocudose for ophthalmic diseases. The company also focuses on developing indications for ophthalmic therapeutics and novel therapeutics for rare diseases, which comprise injectable vitamin k for anticoagulation disorders; low-dose vitamin k to treat ...

3150 Brunswick Pike

Suite 230

Lawrenceville, NJ 08648

United States

Founded in 2001





Key Executives for Aton Pharma, Inc.

Vice President of Commercial Operations - Ophthalmic Business Unit
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Aton Pharma, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at